Endometrial cancer also is known as cancer of the uterus.
Women who have persistently high estrogen levels are at risk for endometrial cancer. Some of the conditions that persistently raise estrogen levels include: obesity, menstrual periods starting at an early age, attaining menopause later in life and never having had children. Post-menopausal women who experience abnormal levels of vaginal bleeding have an increased risk of endometrial cancer.
Why choose the Cancer Therapy & Research Center (CTRC) for endometrial cancer?
The CTRC is the only National Cancer Institute (NCI) designated cancer center in Central and South Texas.
The CTRC partners with national organizations, including the National Cancer Institute, for clinical trial-based treatment options for patients who may need therapies beyond traditional treatments for endometrial cancer.
Our gynecological oncologists specialize in the diagnosis, staging, surgical treatment, chemotherapy and survivorship care of endometrial cancer patients.
Our CTRC team will discuss your case at regularly conducted conferences to determine the best treatment plan for your specific case.
Clinical trials at the CTRC
The CTRC offers care delivered by teams who specialize in all phases of clinical trials. Clinical trials are available to patients of all stages of treatment, from early diagnosis through existing therapies.
As a National Cancer Institute (NCI) designated cancer center, the CTRC also offers experimental treatments and first-in-human clinical trials under special programs for patients.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.